Dermata Therapeutics (DRMA) Q1 2026 Earnings

26MarConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-4.5
-3.12
-1.73
-0.35

Details

Expected EPS
-1.54
Actual EPS
-0.35
Surprise EPS
1.19
Surprise Percent
+77.27%

Description

Dermata Therapeutics (DRMA) has reported earnings of -0.35 per share for Q1 2026.

0 Comments

Share your thoughts